Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
Destany K. Kwon, Mohit Kwatra, Jing Wang, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3736-3736
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 71
Dopamine in the tail of the striatum facilitates avoidance in threat–reward conflicts
Iku Tsutsui‐Kimura, Zhiyu Melissa Tian, Ryunosuke Amo, et al.
Nature Neuroscience (2025)
Open Access | Times Cited: 2
Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions
Lazzaro di Biase, Pasquale Maria Pecoraro, Simona Paola Carbone, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4427-4427
Open Access | Times Cited: 26
A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects
Mauricio Muleiro Álvarez, Gabriela Cano-Herrera, María Fernanda Osorio Martínez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7183-7183
Open Access | Times Cited: 15
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 10
Phytoestrogens: Chemistry, potential health benefits, and their medicinal importance
Vivek P. Chavda, Amit Z. Chaudhari, Pankti C. Balar, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 3060-3079
Open Access | Times Cited: 8
“Advanced” Parkinson's disease: A review
Sana Aslam, Fredric P. Manfredsson, Ashley M. Stokes, et al.
Parkinsonism & Related Disorders (2024) Vol. 123, pp. 106065-106065
Closed Access | Times Cited: 7
Dopaminergic reinforcement in the motor system: Implications for Parkinson's disease and deep brain stimulation
Alessia Cavallo, Wolf‐Julian Neumann
European Journal of Neuroscience (2024) Vol. 59, Iss. 3, pp. 457-472
Open Access | Times Cited: 6
General Treatments Promoting Independent Living in Parkinson’s Patients and Physical Therapy Approaches for Improving Gait—A Comprehensive Review
Dae-Hwan Lee, Bong-Sik Woo, Yong‐Hwa Park, et al.
Medicina (2024) Vol. 60, Iss. 5, pp. 711-711
Open Access | Times Cited: 6
Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies
Yuxun Wei, Hong Li, Yue Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
Deepa Gautam, Ulhas P. Naik, Meghna U. Naik, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1609-1609
Open Access | Times Cited: 14
Neuroactive steroids and Parkinson’s disease: Review of human and animal studies
Mélanie Bourque, Marc Morissette, Thérèse Di Paolo
Neuroscience & Biobehavioral Reviews (2023) Vol. 156, pp. 105479-105479
Closed Access | Times Cited: 14
Auditory cues modulate the short timescale dynamics of STN activity during stepping in Parkinson's disease
Chien-Hung Yeh, Yifan Xu, Wenbin Shi, et al.
Brain stimulation (2024) Vol. 17, Iss. 3, pp. 501-509
Open Access | Times Cited: 5
Application of Network Pharmacology in the Treatment of Neurodegenerative Diseases with Traditional Chinese Medicine
Qiang Chen, Guanghui Chen, Qianyan Wang
Planta Medica (2025)
Open Access
A novel levodopa-carbidopa three-layer gastroretentive tablet for improving levodopa pharmacokinetics
Xiangcheng Zhao, Peng Yan, Hailong Zhang, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2025) Vol. 207, pp. 114633-114633
Closed Access
Impact of Various Qigong and Tai Chi Exercises on Motor Function, Depression, and Quality of Life in Parkinson's Disease Patients: A Network Meta-Analysis
Jiankang Zhao, Ming Yang, Ziye Li, et al.
Research Square (Research Square) (2025)
Closed Access
The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies
Mohammad Yasin Zamanian, Zahra Kamran, Marziye Ranjbar Tavakoli, et al.
Molecular Neurobiology (2025)
Closed Access
G protein-coupled receptors: a golden key to the treasure-trove of neurodegenerative diseases
Huanhuan Li, Zhen Qiao, Xue Xiao, et al.
Clinical Nutrition (2025) Vol. 46, pp. 155-168
Closed Access
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
Emerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment
Vick Key Tew, Muttiah Barathan, Fazlina Nordin, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 284-284
Open Access
Treatment for Dyskinesia in Parkinson's Disease: A Network Meta‐analysis of Randomized Controlled Trials
Rui Yan, Xiaoqing Zheng, Yixuan Yin, et al.
Movement Disorders (2025)
Closed Access
A Bright Future for Photopharmaceuticals Addressing Central Nervous System Disorders: State of the Art and Challenges Toward Clinical Translation
Rudolf L. Z. Ganzoni, Sofie S. Bournons, Erick M. Carreira, et al.
Medicinal Research Reviews (2025)
Closed Access
Cannabidiol Protects Dopaminergic-like Neurons against Paraquat- and Maneb-Induced Cell Death through Safeguarding DJ-1CYS106 and Caspase 3 Independently of Cannabinoid Receptors: Relevance in Parkinson’s Disease
Miguel Mendivil‐Perez, Andrea A. Felizardo-Otalvaro, Marlene Jiménez-Del-Río, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2159-2171
Closed Access | Times Cited: 10
Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia
Tom H. Johnston, Alix M.B. Lacoste, Paula Ravenscroft, et al.
Neuropharmacology (2024) Vol. 248, pp. 109880-109880
Open Access | Times Cited: 3
Bidirectional regulation of levodopa-induced dyskinesia by a specific neural ensemble in globus pallidus external segment
Cong Shen, Bo Shen, Dechen Liu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 6, pp. 101566-101566
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top